Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Vmn2r98 Inhibitors

Vmn2r98 inhibitors pertain to a chemical class designed to interact specifically with a subset of the Vmn2r, or vomeronasal type-2 receptor family. The Vmn2r98 gene is one of the numerous genes in the Vmn2r family that are expressed in the vomeronasal organ (VNO) of certain mammals. The VNO is an olfactory system component that detects pheromones, chemical signals that elicit social and reproductive behaviors. Vmn2r98 inhibitors, therefore, influence the function of the receptor protein encoded by the Vmn2r98 gene. The receptor proteins in the Vmn2r family, including Vmn2r98, are G protein-coupled receptors (GPCRs), which play crucial roles in transducing extracellular signals into cellular responses. The inhibitors of Vmn2r98 are molecules that bind to this receptor, blocking its ability to interact with its natural ligands and consequently inhibiting the signal transduction normally mediated by this receptor.

The chemical composition and structure of Vmn2r98 inhibitors vary widely, as these inhibitors can be designed or discovered through various approaches such as high-throughput screening of chemical libraries, rational drug design, or by studying the structural biology of the Vmn2r98 receptor. Inhibitors may be small organic molecules, peptides, or possibly larger biomolecules that have high affinity and selectivity for the Vmn2r98 receptor over other receptors. Their mode of action involves occupying the ligand-binding site of the receptor or altering its conformation in such a way that the receptor is no longer able to interact with its natural ligands. By blocking such interactions, these inhibitors can modulate the receptor's activity. The study of these inhibitors sheds light on the intricate mechanisms of signal transduction and receptor-ligand interactions in the VNO and contributes to a deeper understanding of the molecular underpinnings of chemosensory function in mammals.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Olmesartan acid

144689-24-7sc-219481
sc-219481A
sc-219481B
sc-219481C
sc-219481D
10 mg
500 mg
1 g
2 g
5 g
$156.00
$208.00
$333.00
$533.00
$1072.00
7
(1)

Olmesartan is an angiotensin II receptor blocker (ARB) that could inhibit Vmn2r98 by blocking angiotensin II type 1 receptors, thereby preventing the potential interaction of angiotensin II with Vmn2r98, should there be a link.

Losartan

114798-26-4sc-353662
100 mg
$130.00
18
(1)

Losartan is another ARB that could indirectly inhibit Vmn2r98 activity by blocking angiotensin receptors, which might interact with Vmn2r98 in a related pathway or signaling event.

Niflumic acid

4394-00-7sc-204820
5 g
$32.00
3
(1)

Niflumic acid blocks chloride channels. If Vmn2r98 activity is dependent on chloride channel function, this compound could indirectly inhibit Vmn2r98.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD 98059 is a MEK inhibitor that impedes the MAPK/ERK pathway. If Vmn2r98 is implicated in this pathway, PD 98059 could indirectly reduce Vmn2r98 activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB 203580 is a p38 MAPK inhibitor. If Vmn2r98 functions are associated with the p38 MAPK pathway, this inhibitor may indirectly reduce its activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that could prevent AKT activation. If Vmn2r98 is involved in the PI3K/AKT pathway, LY294002 could indirectly inhibit Vmn2r98 activity.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$105.00
$299.00
$474.00
15
(1)

Go 6983 is a protein kinase C (PKC) inhibitor. If Vmn2r98 signaling is mediated through PKC, this compound could reduce Vmn2r98 activity.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$458.00
61
(2)

BAPTA-AM is a cell-permeant calcium chelator. If Vmn2r98 relies on intracellular calcium signaling, BAPTA-AM could indirectly inhibit its function.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632 is a ROCK inhibitor. If Vmn2r98 signaling involves the Rho/ROCK pathway, this inhibitor might decrease Vmn2r98 activity.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$91.00
$267.00
13
(1)

ML-7 is a myosin light chain kinase inhibitor. If Vmn2r98 interacts with or is regulated by cytoskeletal dynamics, ML-7 could indirectly inhibit Vmn2r98.